Javle MM - Search Results

1

Regular aspirin use and esophageal cancer risk.

Jayaprakash V, Menezes RJ, Javle MM, McCann SE, Baker JA, Reid ME, Natarajan N, Moysich KB. Jayaprakash V, et al. Among authors: javle mm. Int J Cancer. 2006 Jul 1;119(1):202-7. doi: 10.1002/ijc.21814. Int J Cancer. 2006. PMID: 16450404

2

Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma.

Wilkinson NW, Black JD, Roukhadze E, Driscoll D, Smiley S, Hoshi H, Geradts J, Javle M, Brattain M. Wilkinson NW, et al. J Gastrointest Surg. 2004 May-Jun;8(4):448-53. doi: 10.1016/j.gassur.2004.01.006. J Gastrointest Surg. 2004. PMID: 15120370

3

Carcinoma of the esophagus with mixed basaloid squamous and glandular differentiation: a distinct histological presentation.

Bhagat V, Javle M, Geradts J. Bhagat V, et al. Int J Gastrointest Cancer. 2003;34(2-3):139-42. doi: 10.1385/IJGC:34:2-3:139. Int J Gastrointest Cancer. 2003. PMID: 15361648

4

Risk factors associated with earlier age of onset in familial pancreatic carcinoma.

James TA, Sheldon DG, Rajput A, Kuvshinoff BW, Javle MM, Nava HR, Smith JL, Gibbs JF. James TA, et al. Among authors: javle mm. Cancer. 2004 Dec 15;101(12):2722-6. doi: 10.1002/cncr.20700. Cancer. 2004. PMID: 15534880 Free article.

5

Nuclear or cytoplasmic expression of survivin: what is the significance?

Li F, Yang J, Ramnath N, Javle MM, Tan D. Li F, et al. Among authors: javle mm. Int J Cancer. 2005 Apr 20;114(4):509-12. doi: 10.1002/ijc.20768. Int J Cancer. 2005. PMID: 15578717 Free PMC article. Review.

6

Chemoradiation is a tolerable therapy for older adults with esophageal cancer.

Nallapareddy S, Wilding GE, Yang G, Iyer R, Javle M. Nallapareddy S, et al. Anticancer Res. 2005 Jul-Aug;25(4):3055-60. Anticancer Res. 2005. PMID: 16080565 Free article.

7

Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Khoury T, Chadha K, Javle M, Donohue K, Levea C, Iyer R, Okada H, Nagase H, Tan D. Khoury T, et al. Int J Gastrointest Cancer. 2005;35(3):171-7. doi: 10.1385/IJGC:35:3:171. Int J Gastrointest Cancer. 2005. PMID: 16110118

8

Palliation of malignant dysphagia in esophageal cancer: a literature-based review.

Javle M, Ailawadhi S, Yang GY, Nwogu CE, Schiff MD, Nava HR. Javle M, et al. J Support Oncol. 2006 Sep;4(8):365-73, 379. J Support Oncol. 2006. PMID: 17004508 Review.

9

Combined hepatocholangiocarcinoma: case-series and review of literature.

Bhagat V, Javle M, Yu J, Agrawal A, Gibbs JF, Kuvshinoff B, Nava E, Iyer R. Bhagat V, et al. Int J Gastrointest Cancer. 2006;37(1):27-34. doi: 10.1385/IJGC:37:1:27. Int J Gastrointest Cancer. 2006. PMID: 17290078 Review.

10

Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma.

O'Connor BM, Chadha MK, Pande A, Lombardo JC, Nwogu CE, Nava HR, Yang G, Javle MM. O'Connor BM, et al. Among authors: javle mm. Cancer J. 2007 Mar-Apr;13(2):119-24. doi: 10.1097/PPO.0b013e318046ee1a. Cancer J. 2007. PMID: 17476140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters